In addition, activation of GPRC6A can stimulate androgen biosynthesis pathways to regulate intra-tumoral steroidogenesis in prostate cancer cells [52], and in testicular Leydig cells to stimulate circulating testosterone concentrations. This evidence concerns the gene GPRC6A and prostate carcinoma.